E-LIB Suche - Ergebnisse für: Dean, James P.

1

B-cell Receptor Pathway Mutations Are Infrequent in Patient..:

Woyach, Jennifer A. ; Ghia, Paolo ; Byrd, John C....
Clinical Cancer Research. 29 (2023) 16 - p. 3065-3073 , 2023

Link: https://doi.org/10.1158/..

2

Immune restoration with ibrutinib plus venetoclax in first-..:

Moreno, Carol ; Solman, Isabelle G. ; Tam, Constantine S....
Blood Advances. 7 (2023) 18 - p. 5294-5303 , 2023

Link: https://doi.org/10.1182/..

3

Absence of BTK, BCL2, and PLCG2 Mutations in Chronic Lympho..:

Jain, Nitin ; Croner, Lisa J. ; Allan, John N....
Clinical Cancer Research. 30 (2023) 3 - p. 498-505 , 2023

Link: https://doi.org/10.1158/..

4

Results from a Phase 1b/2 Study of Ibrutinib Combination Th..:

Mar, Nataliya ; Zakharia, Yousef ; Falcon, Alejandro...
Cancers. 15 (2023) 11 - p. 2978 , 2023

Link: https://doi.org/10.3390/..

5

Ibrutinib combination therapy for advanced gastrointestinal..:

Oh, Do-Youn ; Maqueda, Maria Alsina ; Quinn, David I....
BMC Cancer. 23 (2023) 1 - p. , 2023

Link: https://doi.org/10.1186/..

6

First-line treatment of chronic lymphocytic leukemia with i..:

Moreno, Carol ; Greil, Richard ; Demirkan, Fatih...
Haematologica. 107 (2022) 9 - p. 2108-2120 , 2022

Link: https://doi.org/10.3324/..

7

Fixed-duration ibrutinib plus venetoclax for first-line tre..:

Tam, Constantine S. ; Allan, John N. ; Siddiqi, Tanya...
Blood. 139 (2022) 22 - p. 3278-3289 , 2022

Link: https://doi.org/10.1182/..

8

Outcomes of coronavirus disease 2019 (COVID‐19) and risk fa..:

Yue, Xiaomeng ; Hallett, David ; Liu, Yangyang...
European Journal of Haematology. 110 (2022) 2 - p. 177-187 , 2022

Link: https://doi.org/10.1111/..

9

Using ibrutinib in earlier lines of treatment results in be..:

Woyach, Jennifer ; Tedeschi, Alessandra ; Munir, Talha...
Leukemia & Lymphoma. 62 (2021) 13 - p. 3278-3282 , 2021

Link: https://doi.org/10.1080/..

10

Long‐term efficacy of first‐line ibrutinib treatment for ch..:

Allan, John N. ; Shanafelt, Tait ; Wiestner, Adrian...
British Journal of Haematology. 196 (2021) 4 - p. 947-953 , 2021

Link: https://doi.org/10.1111/..

11

Poster: CLL-045: Long-Term Follow-up, Up to 7 Years, in the..:

Burger, Jan ; Barr, Paul ; Owen, Carolyn...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S221 , 2021

Link: https://doi.org/10.1016/..

12

Impact of long-term ibrutinib treatment on circulating immu..:

Solman, Isabelle G. ; Blum, Lisa K. ; Burger, Jan A....
Leukemia Research. 102 (2021) - p. 106520 , 2021

Link: https://doi.org/10.1016/..

13

CLL-045: Long-Term Follow-up, Up to 7 Years, in the RESONAT..:

Burger, Jan ; Barr, Paul ; Owen, Carolyn...
Clinical Lymphoma Myeloma and Leukemia. 21 (2021) - p. S316 , 2021

Link: https://doi.org/10.1016/..

14

Ibrutinib restores immune cell numbers and function in firs..:

Solman, Isabelle G. ; Blum, Lisa K. ; Hoh, Hana Y....
Leukemia Research. 97 (2020) - p. 106432 , 2020

Link: https://doi.org/10.1016/..

15

Long-term safety of single-agent ibrutinib in patients with..:

Coutre, Steven E. ; Byrd, John C. ; Hillmen, Peter...
Blood Advances. 3 (2019) 12 - p. 1799-1807 , 2019

Link: https://doi.org/10.1182/..